n article published in Experimental Biology and Medicine (Volume 244, Issue 10, July, 2019) (https://journals.sagepub.com/doi/pdf/10.1177/1535370219850787 ) reports that noninvasive imaging techniques can be used to study eye development. The study, led by Dr. Xincheng Yao , Richard and Loan Hill Professor of Bioengineering and Ophthalmology at the University of Illinois at Chicago in Chicago Illinois (USA), demonstrates that quantitative optical coherence tomography and angiography can be used to monitor the vascular system during eye development in mouse models. The hyaloid vascular system (HVS) is a transient circulatory system that nourishes the eyes in the ...

Poets have called eyes the windows to the soul. Now, Jefferson and Wills Eye researchers will be able to use eyes as windows into debilitating diseases of the brain. Thomas Jefferson University , in partnership with Wills Eye Hospital and thanks to the generosity of several prescient philanthropists, has launched the world's first center focused on the visual signatures of neurological diseases. The William H. Annesley, Jr., MD '48 EyeBrain Center will explore the connections between the retina, optic nerve, and disorders of the brain, potentially revealing novel treatments for confounding diseases such as stroke, Alzheimer's, Parkinson's, multiple ...

Optovue , the global leader in the development of optical coherence tomography (OCT) and OCT angiography (OCTA), will launch its new AngioWellness™ scan at Vision Expo East in New York , March 21-24, 2019 . The AngioWellness scan utilizes Optovue's advanced AngioVue ® OCTA technology to quickly assess and diagnose new pathologies in patients, including diabetic patients and those who may be at risk for glaucoma. Sample AngioWellness Report AngioWellness combines structural information on retinal and ganglion cell thickness with objective metrics on retinal vasculature into one easy-to-read report. The first of its kind patient-monitoring tool was designed to help eye care professionals ...

Gerig, who is affiliated with Tandon's Visualization, Image, and Data Analysis (VIDA) Center , has developed image analysis techniques for some of medicine's most challenging puzzles. His innovative methodologies – many of which are acknowledged to be the first of their kind – have been applied in a number of research studies on anatomical changes due to disease, therapy and recovery, as well as to such specific conditions as schizophrenia, autism, multiple sclerosis, and Huntington's disease. For example, as part of the Infant Brain Imaging Study, a landmark project funded by the National Institutes of Health (NIH) to identify babies ...

Results from two studies show that a new, non-invasive imaging device can see signs of Alzheimer's disease in a matter of seconds. The researchers show that the small blood vessels in the retina at the back of the eye are altered in patients with Alzheimer's. Even patients who have a family history of Alzheimer's but have no symptoms show these telltale signs. And they showed that they can distinguish between people with Alzheimer's and those with only mild cognitive impairment. Results from these studies are being presented at AAO 2018, the 122 nd Annual Meeting of ...

Steven L. Galetta , MD , the Philip K. Moskowitz, MD Professor and Chair of Neurology at NYU Langone Health, has been awarded the 2018 A.B. Baker Award for Lifetime Achievement in Neurological Education by the American Academy of Neurology for his career contributions to the field. Dr. Galetta received this prestigious honor on Monday, April 23 , during the 2018 American Academy of Neurology Annual Meeting in Los Angeles, California .

Novartis, a global leader in ophthalmology, announced further positive results from two Phase III studies of brolucizumab versus aflibercept. Results showed non-inferiority in primary endpoint, superiority in key retinal health outcomes, and long-lasting effect in patients with neovascular age-related macular degeneration (nAMD), a leading cause of blindness. The results of the head-to-head trials, HAWK and HARRIER, were presented at the American Academy of Ophthalmology (AAO) 2017 Annual Meeting 1 . In neovascular AMD, abnormal blood vessels leak fluid into the eye, ultimately causing damage and blindness 2 . At week 16, relative to aflibercept, 35% fewer brolucizumab 6 mg patients showed presence ...

Wolfram Research Announces Innovator Award Winners for 2017 Leaders in Education and includes Massimo Fazio , a professor at the University of Alabama Birmingham's School of Medicine, where he uses the Wolfram Language for optical coherence tomography and image processing in ophthalmological applications.

"Notal Vision has established a seamless, cloud-based infrastructure that connects healthcare providers and their patients through personalized, home-based monitoring designed to facilitate earlier ocular disease detection," said Quinton Oswald, Chief Executive Officer of Notal Vision. "ForeseeHome® uses a patented technology based upon Preferential Hyperacuity Perimetry (PHP) to identify minute changes in the central visual field before the patient notices any visual symptoms, and is the first application of Notal Vision's cloud-based monitoring platform. Notal Vision is developing a second product that will leverage the platform; home-based optical coherence tomography (OCT) testing. Notal Home OCT testing will generate an alert ...

ambridge Technology, a business unit of Novanta Corporation ("Novanta"), announced today the launch of the DC3000 Plus, a new digital servo driver, adding to its product family of components and scan heads for laser beam steering. The DC3000 Plus builds on the success of its predecessor, the DC3000, which applies digital state space controller technology to optimize speed in laser marking applications. With increased drive current and improved thermal management, the DC3000 Plus now offers higher marking speed and it accurately drives larger mirrors faster. These improvements expand the product line's capabilities in laser converting, micromachining, high power welding ...

The experts at the University of Southern California (USC) Roski Eye Institute , who for 42 years have pursued novel research that address blinding eye diseases, will present their latest groundbreaking studies at the Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting held May 7-11 in Baltimore . "Research is at the heart of what we do at USC , it drives better preventive care, aids in improved diagnoses and creates innovative treatments that preserve, and in some cases, restore vision," said Rohit Varma , MD, MPH, dean of the Keck School of Medicine of USC and director of the USC Roski ...

AngioPlexTM optical coherence tomography (OCT) is a new approach to diagnostic imaging in retinal disease. This technology uses amplitude and phase aspects of the OCT signal and novel algorithms to enable highly detailed visualisation of the retinal microvasculature. This system detects capillary flow rather than the presence of an injected dye. Unlike fluorescein angiography (FA), AngioPlex OCT imaging can discriminate capillaries at the superficial and deep retina and can also generate a colour map of the retinal vessels providing unparalleled views of diseased capillaries and net structures. Retinal and choroidal pathologies that are amenable to AngioPlex OCT examination include diabetic ...

The collaborative team of Drs. Laura Balcer , Peter Calabresi and Elliot Frohman have been selected as the winners of the 2015 Barancik Prize for Innovation in MS Research. This team of physician-scientists have worked together for almost 10 years to produce novel, ground-breaking and impactful research about the anatomy and biology of the retina and other structures of the eye in people with multiple sclerosis (MS). In their more than 50 publications, the team has literally "written the book" when it comes to applying optical coherence tomography (OCT), a common and easy-to-use eye scanning technique, to study MS. Thanks in ...

Research published today in the Proceedings of the National Academy of Sciences (PNAS) demonstrates that technology invented by researchers at Oregon Health & Science University's Casey Eye Institute can improve the clinical management of the leading causes of blindness. Optical coherence tomography (OCT) angiography could largely replace current dye-based angiography in the management of these diseases. OHSU researchers found that OCT angiography has considerable advantages over conventional techniques for the diagnosis and management of macular degeneration, diabetic eye disease and glaucoma, the leading causes of blindness in the United States . "This is a significant breakthrough technology that could fundamentally change ...

Levi & Korsinsky is investigating the Board of Directors of Volcano Corporation ("Volcano" or "the Company") (Nasdaq: VOLC ) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to Royal Philips . Click here to learn more about the investigation: http://zlk.9nl.com/volcano-volc . Under the terms of the transaction, Volcano shareholders will receive $18.00 in cash for each share of Volcano stock they own. The investigation concerns whether the Board of Volcano breached their fiduciary duties to stockholders by failing to adequately shop the Company before agreeing to enter ...

A study using a relatively new imaging tool, optical coherence tomography (OCT), offered a new look at the composition of carotid artery disease and has the potential to alter how physicians understand and treat the disease, a leading cause of stroke. The study, conducted at Baptist Health Lexington between September 2010 and May 2012 , was featured in the June 2014 issue of the Journal of the American College of Cardiology (JACC) Cardiovascular Interventions. Interventional cardiologist Dr. Michael R. Jones served as a principal investigator of the study, which also included neurosurgeons Dr. William H. Brooks and Dr. Christian N. Ramsey ...

Abbott (NYSE: ABT ) today announced it has entered into an agreement to purchase OptiMedica Corporation, a privately held, Silicon Valley-based ophthalmic device company. The acquisition will enable Abbott to expand its vision care business into the femtosecond laser-assisted cataract surgery market. Under the terms of the agreement, Abbott will acquire OptiMedica for $250 million , net of cash, plus additional payments totaling up to $150 million upon completion of certain development, regulatory or sales milestones. Currently, most cataract procedures are performed manually, with the surgeon making incisions into the eye by hand. OptiMedica's Catalys ™ Precision Laser System is designed to ...

 NASA has selected 21 space technology payloads for flights on commercial reusable launch vehicles, balloons, and a commercial parabolic aircraft including "Optical Coherence Tomography (OCT) in Microgravity," Douglas Ebert, Wyle Laboratories, Houston.

The Angiogenesis Foundation released a new white paper, "Advocating for Improved Treatment and Outcomes for Wet Age-Related Macular Degeneration" (AMD). Wet AMD is the most common form of blindness in people 50 years or older in developed nations. The report is based on the Australian Wet Age-Related Macular Degeneration Coalition Expert Summit convened in Sydney, Australia last July by the Angiogenesis Foundation and Macular Degeneration Foundation, where multiple healthcare stakeholders gathered to address barriers to timely and optimal care for Australian patients who suffer from vision loss due to wet AMD. The document summarizes key discussions from the summit and ...

Optical Imaging is an emerging imaging technology that uses light to assess optical properties of tissues, and has a great potential for improving disease prevention, clinical research, medical diagnosis and treatment. The basic principle of optical imaging involves - the detection of emitted photons at pre-defined wavelength ranges when the fluorescent probes in the optical imaging system can be excited by NIR light. Further advancements and breakthroughs in the field of fiber optics and photonics resulted in the emergence of innovative optics based technologies such as Optical Coherence Tomography (OCT), Photo-acoustic Optical imaging, Hyperspectral Imaging and Near-Infrared Spectroscopy (NIRS) that have ...

According to a new market research report " Optical Imaging Market (2013-2018) - Technology Trends And Applications Of Optical Coherence Tomography (OCT), Hyper Spectral Imaging (HSI), Near Infrared Spectroscopy (NIRS) And Photo- Acoustic Tomography (PAT) In Clinical Diagnostics, Clinical Research And Life Sciences With Market Landscape Analysis - Estimates Up To 2018 ",published by MarketsandMarkets the value of Optical Imaging Technologies Market was $915.75 Million in the year 2012 and is expected to reach $1.9 Billion by 2018, at an estimated CAGR of 11.37% from 2013 to 2018. Browse 10 market data tables 36 figures 147 Slides and an in-depth ...

Volcano Corporation (NASDAQ: VOLC ) today announced the pricing of its public offering of $400 million aggregate principal amount of 1.75% convertible senior notes due December 1, 2017 registered under the Securities Act of 1933, as amended. Prior to August 7, 2017 , the notes will be convertible only upon certain circumstances and during certain periods. Upon conversion, holders will receive up to the principal amount of the notes in cash and any excess conversion value in shares of Volcano's common stock. Volcano granted the underwriters of the offering a 13-day option to purchase up to $60 million aggregate principal ...

Fish & Richardson scored a major victory for San Diego based Volcano Corporation in a patent trial regarding medical device technology used to diagnose heart problems. After less than 90 minutes of deliberation, a federal district court jury in Delaware found that Volcano did not infringe two patents asserted by St. Jude Medical Inc. and that another two St. Jude patents were invalid. A fifth St. Jude patent was declared not infringed by the court on the eve of trial. The lawsuit, filed in 2010 by St. Jude, sought to shut down Volcano's rapidly growing cardiac Functional Management business. The ...

Escalon Medical Corp.'s (Nasdaq Market: ESMC) subsidiary, Sonomed Escalon™ announced the release of its new iPad App for the AXIS™ Image Management System at the recent World Ophthalmology Congress held February 16-20 in Abu Dhabi, UAE. Matthew Carnevale, Chief Technical Officer, stated that "the AXIS iPad App is an industry first in ophthalmic diagnostic imaging management, and provides an entirely new level of flexibility and power. A clinician can now view all of their ophthalmic diagnostic images from anywhere at any time on their iPad, including slice-by-slice review of OCT images, fundus images, ultrasound, visual fields and more." The ...